Skip to content
PROGRAMME

PROGRAMME

Please find the preliminary programme for download HERE

The conference starts on Monday 20 April 2020 at 08.00 and ends Wednesday 22 April 2020 at 15.00. A get-together will be held the evening before the conference.


Invited Speakers

Göran Bergström, University of Gothenburg & Sahlgrenska University Hospital, Sweden
How can machine learning advance large population trials? - The Swedish CArdioPulmonary biolmage Study (SCAPIS)

Göran Bergström (MD, PhD) is head of the Clinical Cardiometabolic research group at Wallenberg Laboratory, Sahlgrenska Academy, Gothenburg University and senior consultant in clinical physiology at the Vascular Diagnostic Unit, Sahlgrenska University Hospital. His research group strives to improve and personalize risk prediction of cardiovascular disease.

He is also chair of the Swedish CArdioPulmonary bioImage Study (SCAPIS), which has recruited and extensively phenotype 30,000 subjects aged 50-64 years at six Swedish university hospitals (www.scapis.org). The ultimate goal of SCAPIS is to reduce mortality and morbidity from cardiovascular disease, chronic obstructive pulmonary disease and related metabolic disorders

 

Glenn Flux, Royal Marsden Hospital & Institute of Cancer Research, UK
Personalised treatment planning for molecular radiotherapy
Part 1: The Good - Benefits and opportunities
Part 2: The Bad - Risks and threats

Dr Glenn Flux has been working as a medical physicist for 25 years and has been Head of Radioisotope Physics at the Royal Marsden Hospital and Institute of Cancer Research for 15 years. He leads a team of clinical and research scientists to provide support for nuclear medicine with a research focus on quantitative SPECT/CT and PET/CT imaging and the development of personalised treatment planning in molecular radiotherapy. He is chair or member of several national and international committees including the ICRP 101 task group on radionuclide therapy and the EANM radiation protection group. He has published widely on aspects of physics for radioisotope imaging and therapy and has led many research studies. He is currently focussing on clinical dosimetry-based trials for the treatment of thyroid cancer with radioiodine, supported by the UK Department of Health and the European Commission. He has a strong interest in generating multi-disciplinary local and international collaborations between academic research and clinical practice.

 

Mika Kortesniemi, HUS Medical Imaging Center, University of Helsinki, Finland
From image quality to care outcome - Evolved optimisation process supported by Al/Deep Learning

Dr Mika Kortesniemi works as the Chief Physicist and Adjunct Professor in the HUS Medical Imaging Center, University of Helsinki, Finland. His professional focus is on the quality assurance, dosimetry, optimisation and radiation protection in x-ray modalities, especially the evolving CT technology. The research work is primarily related on radiological optimisation, utilizing anthropomorphic phantoms and Monte Carlo simulations. Dr Kortesniemi is the past chair of European Federation of Organisations in Medical Physics (EFOM) Science Committee, chair of the European Congress of Radiology (ECR) 2020 Physics in Medical Imaging Subcommittee and president of the Third European Congress of Medical Physics (ECMP) 2020. In addition to his primary position in HUS Medical Imaging Center, Dr Kortesniemi is involved in IAEA, ICRP and ESR collaboration, and quality audits in radiology.

 

Sophia Zackrisson, Lund University & Skåne University Hospital, Sweden.
Breast tomosynthesis in screening - From optimization to a large screening trial. 14 years of experience from Malmö, Sweden

Sophia Zackrisson obtained her medical degree at Lund University, Sweden in 1999, became board certified physician in 2002 and radiologist in 2009. She completed her PhD in epidemiology in 2006 with a thesis on mammography screening. In 2011, Zackrisson did a post doc in molecular imaging at the Gambhir Lab, Stanford University, Ca, USA, on Photoacoustic cancer imaging. Zachrisson is currently senior consultant radiologist at Skåne University Hospital Malmö and Associate Professor and Senior Lecturer in Radiology at Lund University, Sweden. She was head of section of oncological imaging at Skåne University Hospital between 2012-2017. Her clinical work involves breast and abdominal imaging. In her role as senior lecturer she is responsible for radiology research and radiological undergraduate teaching.

Zackrisson has initiated several clinical and epidemiological studies within breast cancer imaging, with the most important achievements as PI of the Malmö Breast Tomosynthesis Screening Trial, MBTST. The MBTST is a prospective, population-based screening trial of 15.000 woman, set to investigate the use of digital breast tomosynthesis in screening. Applications of artificial intelligence in screening, mechanical and optical imaging of the breast are areas of the group's current investigations. Metastatic disease and colorectal cancer are other areas of interest. She is an internationally renowned speaker and author of numerous scientific papers and book chapters. She is vice chair of the Swedish Society of Breast Imaging since 2018 and chair of the Swedish Translational Research in Breast Cancer. She is executive board member of EUSOBI since 2017.